A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes (NCT07282600)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, and Type 2 Diabetes
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes. Participation in the study will last about 75 weeks.
Who can join: Review the eligibility criteria below.
Location: Birmingham Clinical Research — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (159 Sites)
Showing the first 25 of 159 sites.
- Birmingham Clinical Research — Birmingham, Alabama
- Cullman Clinical Trials — Cullman, Alabama
- Tucson Clinical Research Institute — Tucson, Arizona
- San Fernando Valley Health Institute — Canoga Park, California
- AMCR Institute — Escondido, California
- NorCal Medical Research, Inc — Greenbrae, California
- Ark Clinical Research — Long Beach, California
- Pacific Clinical Studies — Los Alamitos, California
- Inglewood Clinical — Los Angeles, California
- Care Access - Santa Clarita — Santa Clarita, California
- Encompass Clinical Research — Spring Valley, California
- Diablo Clinical Research, Inc. — Walnut Creek, California
- Care Access - Aurora — Aurora, Colorado
- New England Research Associates, LLC — Bridgeport, Connecticut
- CMR of Greater New Haven, LLC — Hamden, Connecticut
- Arrow Clinical Trials — Daytona Beach, Florida
- Care Access - Delray Beach — Delray Beach, Florida
- Fleming Island Center for Clinical Research — Fleming Island, Florida
- Nature Coast Clinical Research - Inverness — Inverness, Florida
- Jacksonville Center for Clinical Research — Jacksonville, Florida
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami — Miami, Florida
- New Horizon Research Center — Miami, Florida
- Adult Medicine of Lake County, Inc. — Mt. Dora, Florida
- American Research Centers of Florida — Pembroke Pines, Florida
- Clinical Site Partners, LLC dba Flourish Research — Winter Park, Florida
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes — Northridge, California
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight — Tempe, Arizona
- A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity — Tempe, Arizona
- Partnerships for Reducing Overweight and Obesity with Patient-Centered Strategies 2.0 — Boston, Massachusetts
- Impact of Metabolic Health on Sperm Epigenetic Marks in Humans — Boston, Massachusetts
- The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults — Tallahassee, Florida
Explore by condition: All Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.